Flarin Holdings

Flarin Holdings Ltd owns infirst Ltd, which focuses exclusively on the rapid commercialisation and globalisation of Flarin® (patent protected lipid formulation of ibuprofen). Flarin® is the first and only OTC lipid formulated ibuprofen clinically proven to be as effective as prescription-strength ibuprofen – without a prescription1. It is indicated for a wide range of symptoms including relief of rheumatic pain or muscular pain, back pain and the pain of non-serious arthritic conditions caused by swelling, stiffness and inflammation. Flarin’s unique lipid formulation also helps to shield the stomach from damage.